Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Arch Womens Ment Health ; 19(1): 193-6, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25971852

RESUMEN

Cannabis is the most commonly used illicit drug during the perinatal period and has potential risks to the fetus. The purpose of this study is to estimate the 1-year prevalence of cannabis use and identify associated factors for a population of low-income pregnant women in Brazil. We performed a cross-sectional analysis of 831 women surveyed using a structured questionnaire to collect sociodemographic, clinical, and substance use history. The 1-year prevalence of antenatal cannabis use was 4.2 %; reported lifetime use was 9.6 %. The presence of a common mental disorder and active tobacco smoking were independently associated with cannabis use, OR = 3.3 (95 % CI 1.65-6.59) and OR = 6.89 (95 % CI 3.45-13.8), respectively.


Asunto(s)
Cannabis , Fumar Marihuana/epidemiología , Pobreza , Complicaciones del Embarazo/epidemiología , Mujeres Embarazadas/psicología , Adolescente , Adulto , Brasil/epidemiología , Estudios Transversales , Femenino , Humanos , Embarazo , Prevalencia , Factores de Riesgo , Fumar/epidemiología , Factores Socioeconómicos , Encuestas y Cuestionarios
2.
Psychosomatics ; 56(5): 547-55, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25620568

RESUMEN

BACKGROUND: Optimizing alcohol withdrawal treatment is a clinical priority, yet it is difficult to predict on presentation which patients would require benzodiazepines or in which patients withdrawal would be complicated. Detoxification studies typically exclude patients with medical comorbidities, psychiatric comorbidities, or multiple substance use disorders; therefore, it is difficult to generalize their conclusions to all types of patients. OBJECTIVE: This retrospective study with no exclusion criteria identifies the risk factors for complicated withdrawal. METHODS: A retrospective medical record review of 47 veterans admitted to a tertiary veteran's medical hospital for alcohol detoxification. Demographics, blood alcohol level, Charlson Comorbidity Index, drinks per drinking day, pre-psychiatry consult benzodiazepine administration, and length of stay were compared for veterans with complications vs those without. RESULTS: Overall, 21% patients experienced significant complications during their medically-managed detoxification, including behavioral disruptions and delirium tremens. Of the patients, 79% were initially assessed using the Clinical Institute Withdrawal Assessment for Alcohol-Revised scale, and 34% continued to be monitored with the Clinical Institute Withdrawal Assessment for Alcohol-Revised scale during their hospital stay. A Clinical Institute Withdrawal Assessment for Alcohol-Revised scale score ≥15 at presentation was significantly associated with increased odds of complications (p = 0.005). There was a trend toward significance of association of complications with tachycardia, history of delirium tremens, and benzodiazepines being administered before psychiatric consultation. The groups did not significantly differ with respect to age, admission blood alcohol level, Charlson Comorbidity Index, comorbid recent substance abuse, or length of stay. CONCLUSION: Clinical Institute Withdrawal Assessment for Alcohol-Revised scale scores ≥15 at presentation was significantly associated with increased odds of complicated alcohol withdrawal (odds ratio = 28, 95% CI: 2.5-317.6, p = 0.005), which supports findings from previous studies.


Asunto(s)
Alcoholismo/complicaciones , Síndrome de Abstinencia a Sustancias/complicaciones , Delirio por Abstinencia Alcohólica/tratamiento farmacológico , Benzodiazepinas/uso terapéutico , Comorbilidad , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios Retrospectivos , Factores de Riesgo , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Resultado del Tratamiento , Veteranos
3.
J Pain Symptom Manage ; 34(2): 120-5, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17583469

RESUMEN

Previous research has noted that many persons are referred to hospice in the last days of life. The National Hospice and Palliative Care Organization collaborated with Brown Medical School to create the Family Evaluation of Hospice Care (FEHC) data repository. In 2005, 106,514 surveys from 631 hospices were submitted with complete data on the hospice length of stay and bereaved family member perceptions of the timing of hospice care. Of these surveys, 11.4% of family members believed that they were referred "too late" to hospice. This varied from 0 to 28.1% among the participating hospice programs with 30 or more surveys. Among those with hospice lengths of stay of less than a month, only 16.2% reported they were referred "too late." Although the bereaved family member perceptions of the quality of end-of-life care did not vary by length of stay for each of the FEHC domains, the perception of being referred "too late" was associated with more unmet needs, higher reported concerns, and lower satisfaction. Our results suggest that family members' perception of the timing of hospice referral-not the length of stay-is associated with the quality of hospice care. This perception varies substantially among the participating hospice programs. Future research is needed to understand this variation and how hospice programs are delivering high quality of care despite short length of stay.


Asunto(s)
Familia/psicología , Hospitales para Enfermos Terminales , Tiempo de Internación , Calidad de la Atención de Salud , Derivación y Consulta , Anciano de 80 o más Años , Aflicción , Femenino , Encuestas de Atención de la Salud , Humanos , Masculino , Factores de Tiempo , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA